BELGRADE, Mont. --(BUSINESS WIRE)--Feb. 25, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended December

BELGRADE, Mont. --(BUSINESS WIRE)--Feb. 19, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger , and CFO, John Gandolfo , will present at the

BELGRADE, Mont. --(BUSINESS WIRE)--Feb. 4, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger , and CFO, John Gandolfo , will present at the

Fourth Quarter Revenue in the range of $8.15 million to $8.28 million , an increase of 4% sequentially, and 1.5% over the same period last year. Fourth Quarter Biologics Revenue in the range of $8.02 million to $8.07 million , up 5.0% sequentially and 4.5% over the same period last year.

BELGRADE, Mont. --(BUSINESS WIRE)--Jan. 15, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo , will present at the Noble Financial Tenth Annual